|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Nigerian-German Chemicals Plc
Main Activities: Chemical Manufacturing - Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Nigerian-German Chemicals Plc Headquarters Plot 144 Oba Akaran Avenue P.O. Box 261 Ikeja, Lagos State Nigeria ; Ikeja; Lagos |
Status: Listed Legal Form: Other non-liability limited Operational Status: Operational ISIN CODE : NGNIGGERMAN3 Financial Auditors: Akintola Williams Deloitte (2010) Incorporation Date: December 18, 1963 Total Employees: 400 Tel: 234 1 4968220 |
|
Company Description |
| NGC is one of Nigeria's premier manufacturers and distributors of pharmaceutical, consumer products and oil & gas field chemicals. Born out of Hoechst Nigeria, NGC has over 45 years pedigree in manufacturing quality products. Building on its solid multinational heritage, NGC's commitment to 'best practice' in business management and the pursuit of manufacturing excellence has enabled it to forge strategic relationships with a number of blue chip companies to complement its long standing tradition | ||
|
||
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2011 Y (cons) |
2010 Y (cons) |
|
 | ||
| Non-Audited | Audited | |
| ||
| WVB Company Financials | WVB Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
8,375,571 |
7,460,106 |
| ||
Current Assets |
1,863,865 |
1,901,449 |
| ||
Total Liabilities |
5,697,898 |
4,987,646 |
| ||
Shareholders Equity |
2,677,673 |
2,472,460 |
| ||
Current Liabilities |
5,697,898 |
4,072,781 |
| ||
| * All the accounts are in NGN. | ||
Income Statement
| ||
Total Operating Revenue |
3,240,000 |
3,989,908 |
| ||
Operational Profit (Loss) |
-315,837 |
92,146 |
| ||
Net Profit (Loss) |
538,072 |
-468,497 |
| ||
| * All the accounts are in NGN. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
6.42% |
-6.28% |
| ||
Annualised Return on Assets (ROA) |
6.42% |
-6.28% |
| ||
Return on Equity (ROE) |
20.09% |
-18.95% |
| ||
Annualised Return on Equity (ROE) |
20.09% |
-18.95% |
| ||
Return on Sales (ROS) |
16.61% |
-12.63% |
| ||
Return on Capital |
20.09% |
-15.55% |
| ||
Gross Profit Margin |
39.44% |
44.94% |
| ||
Operating Profit Margin |
-5.55% |
-0.17% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
6.06x |
12.66x |
| ||
Inventory Turnover |
2.72x |
2.60x |
| ||
Current asset turnover |
1.74x |
1.95x |
| ||
Fixed-asset turnover |
0.50x |
0.67x |
| ||
Asset Turnover |
0.39x |
0.50x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
-179,915 |
92,146 |
| ||
EBITDA |
-179,915 |
274,451 |
| ||
Enterprise value |
1,809,384 |
4,285,766 |
| ||
Enterprise Value / EBITDA |
-10.06 |
15.62 |
| ||
Bookvalue (BV) |
8,118,480 |
5,340,446 |
| ||
Net Cash |
-5,630,825 |
-4,041,285 |
| Liquidity Ratios | ||
| ||
Current Ratio |
32.71% |
46.69% |
| ||
Quick ratio |
20.05% |
27.42% |
| ||
Doom's day ratio |
1.18% |
0.77% |
| Leverage Ratios | ||
| ||
Leverage ratio |
312.79% |
301.73% |
| ||
Interest Coverage Ratio |
0% |
15.85% |
| ||
Debt to equity |
212.79% |
201.73% |
| ||
Debt to total assets |
68.03% |
66.86% |
| ||
Long Term Debt to Capital |
0% |
92.25% |
| ||
Debt / Enterprise Value |
14.21% |
49.46% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
-9.00 |
8.01 |
| ||
Price/Book Ratio |
0.20 |
0.41 |
| ||
Market Cap / Net cash |
-0.29 |
-0.54 |
| Trend Ratios | ||
| ||
Revenue Trend |
87.36% |
|
| ||
Net Income Trend |
-114.85% |
|
| ||
Operating Income Trend |
-195.25% |
|
| ||
 |